Fundz

QurAlis Appoints Doug Williamson and Jason Brown to Key Executive Positions

PRIVATEJun 13, 2024

Position

Chief Operating Officer

Company

QurAlis

Jason Brown
jason.brown@quralis.com
CambridgeBiotechnologyHealthcareHealth CareTherapeutics

Description

QurAlis has appointed Doug Williamson as the Chief Medical Officer and Jason Brown as the Chief Financial Officer. Kasper Roet, PhD, the CEO, expresses confidence in their ability to contribute to the company's next phase of growth and advancement in clinical development. The company also announced the appointment of Shafique Virani to its board of directors.

Quick answer

QurAlis Appoints Doug Williamson and Jason Brown to Key Executive Positions (June 13, 2024). QurAlis is based in Cambridge, Massachusetts, United States.

Who is the new Chief Operating Officer at QurAlis?
QurAlis named Jason Brown Chief Operating Officer, announced June 13, 2024.
What did QurAlis announce on June 13, 2024?
QurAlis has appointed Doug Williamson as the Chief Medical Officer and Jason Brown as the Chief Financial Officer. Kasper Roet, PhD, the CEO, expresses confidence in their ability to contribute to the company's next phase of growth and advancement in clinical development.
What does QurAlis do?
QurAlis is a pioneering neuroscience company dedicated to developing precision medicines that target the root causes of neurodegenerative and neurological diseases.
Where is QurAlis based?
QurAlis is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
AbbVie Inc. (June 20, 2024), MBX Biosciences, Inc. (June 25, 2024), Crinetics Pharmaceuticals (May 30, 2024) and Crispr Therapeutics (May 24, 2024) also announced leadership changes within 45 days of QurAlis.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at QurAlis, and when

A new leader at QurAlis brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day QurAlis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at QurAlis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at QurAlis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

QurAlis

Location

Cambridge, Massachusetts, United States

About

QurAlis is a pioneering neuroscience company dedicated to developing precision medicines that target the root causes of neurodegenerative and neurological diseases. With leading expertise in amyotrophic lateral sclerosis (ALS), the company is committed to translating scientific breakthroughs into transformative therapies. Guided by collaboration, scientific rigor, and compassion, QurAlis is advancing a robust pipeline of disease-modifying treatments driven by genetics and clinical biomarkers to improve the lives of patients with severe neurological conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment QurAlis changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sandy (Klein)
Senior decision-maker at this company
••••••••@••••••••

See Sandy (Klein)'s verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for QurAlis's next move

Learn about Strategic plan

QurAlis changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.